Oncolytic Transcriptionally Retargeted Adenovirus Expressing Nitroreductase in Combination with Antiangiogenic Drug RAD001

被引：0
|
作者：
Lukashev, Alexander N. [1 ]
Homicsko, Krizstian G. [1 ]
Fuerer, Cristophe [2 ]
Iggo, Richard [1 ]
机构：
[1] Univ St Andrews, Bute Med Sch, St Andrews, Fife, Scotland
[2] ISREC, Epalinges, Switzerland
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.716
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
640
引用
收藏
页码：S246 / S246
页数：1
相关论文
共 50 条
  • [31] FP3, a Novel VEGF Blocker, Expressing Oncolytic Adenovirus Induces Potent Antiangiogenic and Antitumor Efficacy
    Choi, Il-Kyu
    Shin, Hyewon
    Oh, Eonju
    Yoo, Ji Young
    Hwang, June Kyu
    Yu, De-Chao
    Yun, Chae-Ok
    MOLECULAR THERAPY, 2015, 23 : S131 - S131
  • [32] Combination of antiangiogenic therapy using the mTOR inhibitor RAD001 (everolimus) and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: Dose-finding study
    Joka, Mareile
    Boeck, Stefan Hubert
    Hosius, Christian
    Decroix, Laetitia
    May, Christoph
    Alberter, Barbara
    Pustowka, Anette
    Heinemann, Volker
    Bruns, Christiane
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [33] Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma
    David A. Reardon
    Timothy Cloughesy
    Jeremy Rich
    W. K. Alfred Yung
    Lotus Yung
    Clifford DiLea
    Jerry Huang
    Margaret Dugan
    William Mietlowski
    Andrea Maes
    Charles Conrad
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 281 - 287
  • [34] Pharmacokinetic drug interaction between AEE788 and RAD001 causing thrombocytopenia in patients with glioblastoma
    Reardon, David A.
    Cloughesy, Timothy
    Rich, Jeremy
    Yung, W. K. Alfred
    Yung, Lotus
    DiLea, Clifford
    Huang, Jerry
    Dugan, Margaret
    Mietlowski, William
    Maes, Andrea
    Conrad, Charles
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (01) : 281 - 287
  • [35] Combination of Rad001 (Everolimus) and Propachlor Synergistically Induces Apoptosis through Enhanced Autophagy in Prostate Cancer Cells
    Tai, Sheng
    Sun, Yin
    Liu, Nan
    Ding, Boxiao
    Hsia, Elaine
    Bhuta, Sunita
    Thor, Ryan K.
    Damoiseaux, Robert
    Liang, Chaozhao
    Huang, Jiaoti
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (06) : 1320 - 1331
  • [36] The combination of RAD001 and NVP-BKM120 synergistically inhibits the growth of lung cancer in vitro and in vivo
    Ren, Hui
    Chen, Mingwei
    Yue, Ping
    Tao, Hui
    Owonikoko, Taofeek K.
    Ramalingam, Suresh S.
    Khuri, Fadlo R.
    Sun, Shi-Yong
    CANCER LETTERS, 2012, 325 (02) : 139 - 146
  • [37] Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cells
    Tai, Sheng
    Xu, Lingfan
    Xu, Ming
    Zhang, Ligang
    Zhang, Yangyang
    Zhang, Kaipin
    Zhang, Li
    Liang, Chaozhao
    ONCOTARGET, 2017, 8 (07) : 11206 - 11218
  • [38] PHASE I TRIAL OF RAD001 (EVEROLIMUS) IN COMBINATION WITH RADIOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Deutsch, E.
    Lepechoux, C.
    Pignon, J. P.
    Tao, Y. T.
    Rivera, S.
    Bourgier, B. C.
    Angokai, M.
    Bahleda, R.
    Slimane, K.
    Angevin, E.
    Besse, B. B.
    Soria, J. C.
    ANNALS OF ONCOLOGY, 2013, 24 : 9 - 9
  • [39] Esophageal Cancer Treatment Using an Interferon-Expressing Oncolytic Adenovirus in Combination with Chemotherapy and Radiation
    LaRocca, Christopher J.
    Oliveira, Amanda R.
    Davydova, Julia
    Yamamoto, Masato
    MOLECULAR THERAPY, 2014, 22 : S253 - S253
  • [40] A Phase I Pilot Study of the Oral mTOR Inhibitor RAD001 in Combination with Capecitabine for Metastatic Breast Cancer.
    Chen, C. S.
    Chen, M. M.
    Imaoka, R. T.
    Svahn, T.
    Guardino, A. E.
    CANCER RESEARCH, 2009, 69 (24) : 860S - 860S
12345